Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07507266Not Yet Recruiting

Emotions From Salivary Biomarkers in an Architectural Context

Role: lead

NCT07522372Active Not Recruiting

Evaluation of the Effect of Kefir Consumption

Role: lead

NCT07507253Recruiting

Pilot Study on the Correlation Between Accelerations Experienced

Role: lead

NCT06149351Recruiting

Salivary Biomarkers for Concussion

Role: lead

NCT07320040Recruiting

Evaluation of Emotion-related Salivary Molecular Biomarkers

Role: lead

All 5 trials loaded